Lantheus Holdings, Inc. (LNTH)
65.17
-1.40
(-2.10%)
USD |
NASDAQ |
Dec 16, 16:00
65.12
-0.05
(-0.08%)
After-Hours: 05:16
Lantheus Holdings Research and Development Expense (Annual): 168.10M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cytokinetics, Inc. | 329.88M |
| Iovance Biotherapeutics, Inc. | 282.34M |
| Day One Biopharmaceuticals, Inc. | 227.70M |
| Travere Therapeutics, Inc. | 217.50M |
| Xenetic Biosciences, Inc. | 2.584M |